The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers - a study of the National Cancer Institute of Canada Clinical Trials Group-Reference-Cited by-同舟云学术

The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers - a study of the National Cancer Institute of Canada Clinical Trials Group

Published:2004-07 Issue:4 Volume:14 Page:650-658
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:Int J Gynecol Cancer

Author:

Ma B. B. Y.,Oza A.,Eisenhauer E.,Stanimir G.,Carey M.,Chapman W.,Latta E.,Sidhu K.,Powers J.,Walsh W.,Fyles A.

Publisher

BMJ

Subject

Obstetrics and Gynaecology,Oncology

Reference65 articles.

1. Stage IV endometrial carcinoma: a 10 year review of patients.

2. Oral Medroxyprogesterone Acetate in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Dose-Response Study by the Gynecologic Oncology Group

3. Tamoxifen in the Treatment of Advanced or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

4. Endometrial carcinoma: Steroid receptors and response to medroxyprogesterone acetate

5. Oestrogen and Progestin Receptors as Prognostic Indicators in Endometrial Cancer: A review of the literature

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma;BMC Cancer;2023-11-03

2. Dedifferentiated umbilical metastases from low grade endometrioid endometrial adenocarcinoma complicated by super-obesity: A case report;International Journal of Surgery Case Reports;2023-07

3. Evolution of systemic therapy for disseminated endometrial cancer: literature review;Malignant tumours;2023-06-21

4. Do Not Forget about Hormonal Therapy for Recurrent Endometrial Cancer: A Review of Options, Updates, and New Combinations;Cancers;2023-03-16

5. A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor–Positive Recurrent Endometrial Cancer;Journal of Clinical Oncology;2023-01-20